20 April 2015
RIGHTMOVE PLC
DIRECTOR/PDMR SHAREHOLDING
Rightmove plc (the "Company") has received the following notifications today
from, Peter Brooks-Johnson, Chief Operating Officer:
Peter Brooks-Johnson confirmed that today he exercised his right to acquire
11,689 deferred shares awarded at nil cost in March 2013 in respect of his 2012
financial year bonus, which vested in March 2015. Peter Brooks-Johnson
subsequently sold all the ordinary shares of 1p each in the Company ("ordinary
shares") received at an average price of 3082.3587p per share. The number of
ordinary shares sold represented 0.012% of the ordinary shares in issue (less
shares held in treasury) prior to such sale.
Following these transactions, the beneficial shareholding of Peter
Brooks-Johnson is 22,483 ordinary shares representing 0.023% of the ordinary
shares in issue (excluding shares held in treasury). He also holds executive
and Sharesave options over 270,428 ordinary shares, deferred share awards over
13,238 ordinary shares and 123,538 performance shares.
This announcement is made under the UKLA's Disclosure and Transparency Rule
3.1.4R.
Ends
Name and contact number for queries:
Jenny Warburton 0207 087 0739
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.